Results
74,078 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $258K 1,014 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $258K 1,014 sh |
| Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Sloan Lindsay LVP & Chief Accounting Officer |  CMCCOMMERCIAL METALS CoTax withholding | F | $16K 245 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Levine Jon RDirector, President and CEO, 10% Owner |  MRMDMARIMED INC.Option exercise | M | — 30.6K sh | Oct 15, 2026 traded Oct 15, 2026 |
| 9 | Murphy Mark J.EVP & Chief Financial Officer |  MUMICRON TECHNOLOGY INCOption exercise | M | — 22.8K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Arnzen April SEVP and Chief People Officer | MUMICRON TECHNOLOGY INC Grant or award | A | — 14.4K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Raji Vijaye GaneshDirector |  AMPLAmplitude, Inc.Grant or award | A | — 37.9K sh | Oct 15, 2026 traded Oct 15, 2026 |
| 9 | Allen Scott R.CVP, Chief Accounting Officer | MUMICRON TECHNOLOGY INC Grant or award | A | — 9,081 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Alexandria Venture Investments, LLC10% Owner |  TRXBTRex Bio, Inc.Derivative conversion | C | — 1.03M sh | Oct 15, 2026 traded Oct 13, 2026 |
| 8 | Chylak Robert NestorSenior Vice President |  KLICKULICKE & SOFFA INDUSTRIES INCTax withholding | F | $102K 1,157 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $81K 105 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $167K 219 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 74 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $98K 127 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $163K 211 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $51K 66 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $173K 224 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $218K 283 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $207K 271 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $94K 121 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $147K 192 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $214K 279 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 7 |  Silverman JoshDirector, Executive Chair of the Board |  ETSYETSY INCOption exercise · 10b5-1 plan | M | — 714 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 7 | Eddy Robert W.Director, President & CEO |  BJBJ's Wholesale Club Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $517K 5,000 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 7 | Silverman JoshDirector, Executive Chair of the Board | ETSYETSY INC Option exercise · 10b5-1 plan | M | — 417 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 6 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Option exercise | M | — 20.5K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Option exercise | M | — 24.1K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 600 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $171K 640 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 476 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $220K 883 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Option exercise | M | — 24.1K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Hanson JohnChief of Staff |  OKLOOklo Inc.Option exercise | M | — 961 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Renner AlexandraChief Product Officer | OKLOOklo Inc. Option exercise | M | — 1,521 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $42K 55 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $9,242 12 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Randle Race A.CEO |  MLPMAUI LAND & PINEAPPLE CO INCTax withholding | F | — 2,538 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $12K 16 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Silverman JoshDirector, Executive Chair of the Board | ETSYETSY INC Option exercise · 10b5-1 plan | M | $4,067 383 sh | Oct 15, 2026 traded Oct 8, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $19K 25 sh | Oct 15, 2026 traded Oct 14, 2026 |